Mural Oncology plc
MURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $4 | $3 | $0 | $1 |
| Gross Profit | -$4 | -$3 | $0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $111 | $162 | $167 | $160 |
| G&A Expenses | $28 | $31 | $18 | $16 |
| SG&A Expenses | $28 | $30 | $18 | $16 |
| Sales & Mktg Exp. | $0 | -$1 | $0 | $0 |
| Other Operating Expenses | -$4 | $0 | $0 | -$1 |
| Operating Expenses | $135 | $192 | $185 | $174 |
| Operating Income | -$138 | -$195 | -$185 | -$175 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $10 | -$1 | $0 | $0 |
| Pre-Tax Income | -$129 | -$195 | -$185 | -$175 |
| Tax Expense | $0 | $12 | $5 | $0 |
| Net Income | -$129 | -$207 | -$190 | -$175 |
| % Margin | – | – | – | – |
| EPS | -7.58 | -12.43 | -11.37 | -10.51 |
| % Growth | 39% | -9.3% | -8.2% | – |
| EPS Diluted | -7.58 | -12.43 | -11.37 | -10.51 |
| Weighted Avg Shares Out | 17 | 17 | 17 | 17 |
| Weighted Avg Shares Out Dil | 17 | 17 | 17 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $4 | $3 | $2 | $1 |
| EBITDA | -$125 | -$193 | -$183 | -$174 |
| % Margin | – | – | – | – |